Investment revenue ratio of pharmaceutical CDMO in Italy 2016-2021
The investment revenue ratio of pharmaceutical contract manufacturing organizations (CDMO) in Italy increased considerably between 2016 and 2021, more than doubling in value. In fact, it was equal to nine percent in 2016, while by 2021 it peaked at 20.1 percent. This statistic shows the investment revenue ratio of pharmaceutical contract manufacturing organizations in Italy from 2016 to 2021.